127 |
Rajasekhar, Megha (57215545833); Simpson, Julie A (55568943500); Ley, Benedikt (55004117400); Edler, Peta (58608629200); Chu, Cindy S (57207278580); Abreha, Tesfay (14031097700); Awab, Ghulam R (36016082300); Baird, J Kevin (15921267800); Bancone, Germana (23479268200); Barber, Bridget E (36561132900); Grigg, Matthew J (55507854900); Hwang, Jimee (35067936600); Karunajeewa, Harin (6602655545); Lacerda, Marcus V G (8836255900); Ladeia-Andrade, Simone (14025832100); Llanos-Cuentas, Alejandro (6701 |
Primaquine dose and the risk of haemolysis in patients with uncomplicated Plasmodium vivax malaria: a systematic review and individual patient data meta-analysis |
The Lancet Infectious Diseases |
6 |
Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, VIC, Australia; WorldWide Antimalarial Resistance Network (WWARN), Asia-Pacific Regional Centre, Melbourne, VIC, Australia; Global Health Division, Menzies School of Health Research and Charles Darwin University, Darwin, NT, Australia; Department of Infectious Diseases, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, Australia; Shoklo Malaria Research Unit, Mahidol Oxford Tropical Medicine Research Unit (MORU), Faculty of Tropical Medicine, Mahidol University, Mae Sot, Thailand; Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom; ICAP, Columbia University Mailman School of Public Health, Addis Ababa, Ethiopia; MORU, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand; Department of Clinical Tropical Medicine, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand; Nangarhar Medical Faculty, Nangarhar University, Jalalabad, Afghanistan; Oxford University Clinical Research Unit Indonesia, Faculty of Medicine Universitas Indonesia, Jakarta, Indonesia; QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia; Infectious Diseases Society Sabah-Menzies School of Health Research Clinical Research Unit, Kota Kinabalu, Malaysia; US President's Malaria Initiative, Malaria Branch, US Centers for Disease Control and Prevention, Atlanta, GA, United States; Institute for Global Health Sciences, University of California San Francisco, San Francisco, CA, United States; Department of Medicine-Western Health, Melbourne Medical School, The University of Melbourne, St Albans, VIC, Australia; Fundação de Medicina Tropical Dr Heitor Vieira Dourado, Manaus, Brazil; Instituto Leônidas e Maria Deane, Fiocruz, Manaus, Brazil; University of Texas Medical Branch, Galveston, TX, United States; Laboratory of Parasitic Diseases, Oswaldo Cruz Institute, Fiocruz, Rio de Janeiro, Brazil; Global Health and Tropical Medicine, Institute of Hygiene and Tropical Medicine, NOVA University of Lisbon, Lisbon, Portugal; Unit of Leishmaniasis and Malaria, Instituto de Medicina Tropical Alexander von Humboldt, Universidad Peruana Cayetano Heredia, Lima, Peru; Central Department of Microbiology, Tribhuvan University, Kirtipur, Nepal; Department of Infectious Diseases, Kasturba Medical College, Manipal Center for Infectious Diseases, Prasanna School of Public Health, Manipal Academy of Higher Education, Manipal, India; Department of Parasitology, Faculty of Medicine, University of Indonesia, Jakarta, Indonesia; Oxford University Clinical Research Unit, Hospital for Tropical Diseases, Ho Chi Minh City, Viet Nam; WWARN, Oxford, United Kingdom; Infectious Diseases Data Observatory (IDDO), Oxford, United Kingdom; General and Subspecialty Medicine, Grampians Health—Ballarat, Ballarat, VIC, Australia |
NJW, (089179); Shoklo Malaria Research Unit, (220211); Centers for Disease Control and Prevention, CDC; Bill and Melinda Gates Foundation, BMGF; Wellcome Trust, WT; National Health and Medical Research Council, NHMRC, (1194702, 1196068, 2008501, 2016792, 2017436); Conselho Nacional de Desenvolvimento Científico e Tecnológico, CNPq, (223253/Z/21/Z); Capability Systems Centre, CSC |
Funding text 1: JAS, BEB, MJG, RNP, and RJC are supported by Australian National Health and Medical Research Council (NHMRC) Investigator Grants (1196068, 2016792, 2017436, 2008501, and 1194702, respectively). CSC and the Shoklo Malaria Research Unit (grant 220211), and CSC, NJW, and FN (grant 089179) are supported by the Wellcome Trust. JH receives salary support from the US President's Malaria I |
Elsevier Ltd |
Q1 |
|
|